TOLEDO, Ohio, April 10, 2026 — SSOE Group (www.ssoe.com), an internationally ranked architecture and engineering firm, announced today that Greg Verhoff, Pharmaceutical Business Leader, will facilitate the panel discussion “Cost-Effective Pharmaceutical Manufacturing for Global Drug Accessibility” at INTERPHEX 2026, taking place April 21‒23 at the Jacob K. Javits Convention Center in New York City. David Wilson, Master Mechanical Engineer at SSOE, will participate as a panelist, alongside experts from across the pharmaceutical manufacturing ecosystem, including Design / Build firm Hodess Cleanrooms, air filtration manufacturer Camfil, and full service CRDMO BioTechnique.
INTERPHEX, one of the pharmaceutical industry’s premier events, brings together leaders across engineering, operations, and supply chain to explore the technologies and strategies shaping the next generation of pharmaceutical production.
As pressure mounts globally for affordable therapies, resilient supply chains, and expanded domestic manufacturing capacity, increasing attention is being placed on the upstream factors that influence drug costs. Manufacturing infrastructure, utilities, equipment, and regulatory compliance all contribute significantly to a product’s Cost of Goods (COGs), making facility strategy a critical factor in long-term production economics. Decisions made during early planning and design stages can influence a facility’s operational efficiency, scalability, and lifecycle cost for decades.
SSOE Group Pharmaceutical Business Leader Greg Verhoff will moderate the panel. He noted, “When people talk about drug affordability, the conversation often starts at pricing policy. But long before pricing enters the equation, the economics of manufacturing have already been shaped—by facility design, production strategy, and the decisions made during early project planning. Those choices influence everything from cost of goods to speed-to-market, and ultimately whether therapies can reach patients at scale.”
The INTERPHEX panel will examine how cleanroom designers can leverage advanced modeling techniques during early design phases to establish very clear performance criteria for mechanical systems. This increased accuracy allows client engineering and regulatory team members to be confident in future performance of their facility. This mutual confidence from client and designer results in mechanical systems that are right sized and normally results in smaller or less complex systems that reduce initial capex cost, annual energy costs, and maintenance life cycle costs.
SSOE partners with leading pharmaceutical and life science manufacturers to deliver cGMP-compliant production environments that balance operational performance, regulatory rigor, and long-term manufacturing flexibility to ensure facilities can evolve alongside rapidly changing therapies, technologies, and regulatory expectations. The firm’s experience spans cleanrooms, API facilities, laboratories, pharmaceutical production environments, and Commissioning and Qualification supporting global pharmaceutical supply.